Global Stakeholder Perspectives on Real-World Data and Evidence in Health Technology Assessment: An Exploratory Study. [PDF]
Zisis K +3 more
europepmc +1 more source
Editorial: Utilizing real-world evidence for better endocrine health management. [PDF]
Mei M, Lopes LC, Li C.
europepmc +1 more source
A Cross-Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real-World Evidence. [PDF]
Melinder M +11 more
europepmc +1 more source
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25. [PDF]
Arora P, Ramagopalan SV.
europepmc +1 more source
Infection risk associated with teclistamab in relapsed/refractory multiple myeloma: a systematic review and meta-analysis of clinical trial and real-world evidence. [PDF]
Huang ZY, Chen J, Zhu B, Liu XL.
europepmc +1 more source
Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real-World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps. [PDF]
Cresswell K +12 more
europepmc +1 more source
Advancing real-world evidence harmonization: lessons from the UK, EMA and global policy frameworks. [PDF]
Sagkriotis A.
europepmc +1 more source
Time to accelerate rare disease research: AI-powered in silico trials, digital twin-driven RCTs and decision-grade real-world evidence. [PDF]
Belančić A +5 more
europepmc +1 more source
Comparative Analysis of Pathology Foundation Models for Automated Detection of Tertiary Lymphoid Structures in Hematoxylin-and-Eosin-Stained Digital Pathology Images. [PDF]
Guan M +9 more
europepmc +1 more source
Integrating Artificial Intelligence, Circulating Tumor DNA, and Real-World Evidence to Optimize Hematologic Clinical Trials: Toward Adaptive and Learning Trial Designs. [PDF]
Mahmoud AM +4 more
europepmc +1 more source

